Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
Aedifica reports strong H1 growth and confirms synergies after merger with Cofinimmo
Aedifica reports an EPRA result per share of €2.71 (+5%) for H1 2026 and a 62% rise in rental income following the merger with Cofinimmo. Management confirms run‑rate synergies of at least €16 million by 2027 (€5–5.5 million for 2026) and an average occupancy of the care‑home portfolio of 91%. The group maintains its full‑year guidance for EPRA result per share at €5.35 but shows a gearing ratio of 42.7% and a refinancing need of around €2.2 billion for 2027–2028. » More on de.investing.com
Aedifica increases rental income 6.8% in 2025 and raises dividend
Aedifica reports rental growth of 6.8% in fiscal 2025 to €361m and an EPRA result of €244.8m (+4.3%). Adjusted earnings per share rose to €5.15, beating the company’s guidance and market consensus; an EPRA earnings per share of €5.20 is expected for 2026. The operating margin and occupancy rates improved, portfolio value stands at €6.3bn, and the EPRA LTV ratio fell to 39.7%. Aedifica announces a dividend of €4.00 per share, up 2.6% year on year. » More on de.investing.com
Aedifica receives approval for takeover of Cofinimmo subject to conditions
Belgian competition authority has approved Aedifica’s acquisition of Cofinimmo but requires the sale of healthcare properties in Belgium worth €300m over several years. With the clearance, the acceptance period begins on 30 January and runs until 2 March; results will be announced on 6 March and the first payment is scheduled for 13 March. The merger would create the largest listed healthcare real estate REIT in Europe with a portfolio of over €12bn. » More on de.investing.com
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | June 2026 | YoY |
|---|---|---|
| Revenue | 186.45m | 106.99% |
| Gross profit | 167.89m | 101.19% |
| Net profit | 77.24m | 53.44% |
| EBITDA | 120.66m | 49.95% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €5.3bn |
Number of shares | 83.47m |
52-week high/low | €80.05 - €60.35 |
Dividend yield | 6.31% |
Dividends TTM | €4.00 |
Beta | 0.96 |
P/E ratio | 5.58 |
PEG ratio | 0.03 |
P/B ratio | 0.83 |
P/S ratio | 10.85 |
Company profile
Aedifica is a Belgian listed company that offers sustainable real estate solutions to professional operators that provide care to people with care needs throughout Europe. To realise that mission, Aedifica has specialised in investments in quality European healthcare real estate, with a particular focus on the care needs of the elderly. Aedifica has established itself in recent years as a leader in the European listed real estate sector and has the ambition to further expand this position in the coming years. By investing in quality buildings that generate recurring and indexed rental income and offer potential for capital gains, Aedifica aims to offer its shareholders a reliable and sustainable real estate investment with an attractive yield. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019). Since March 2020, Aedifica is part of the BEL 20, the leading share index of Euronext Brussels.
| Name | Aedifica |
| CEO | Stefaan Gielens |
| Headquarters | Brussels,
bu Belgium |
| Website | |
| Sector | Real Estate |
| Industry | Diversified REITs |
| IPO | 23/10/2006 |
| Employees | 127 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Euronext | AED.BR |
Pnk | AEDFF |
Brussels Stock Exchange | AED.BR |
Frankfurt | AOO.F |
Düsseldorf | AOO.DU |
London | 0DKX.L |
München | AOO.MU |